MSPEECH (multiple sclerosis monitoring through speech interaction in clinic and at home): a Living Lab study protocol for co-created, speech-based digital biomarkers in multiple sclerosis

• by Tina Lemkau, Hernan Inojosa, Anja Dillenseger, Johannes Tröger, Janna Hermann, Nicklas Linz, Stephen Gilbert, Tjalf Ziemssen

• July 16, 2026

Real-world practices and challenges of radiologically isolated syndrome: results of a cross-sector survey by the DACH MS guidelines group

• by Friederike Held, Antonios Bayas, Katharina Christe, Christian Dettmers, Burkhard Domurath, Juliane Ebert, Edeltraud Faßhauer, Peter Flachenecker, Jutta Gärtner, Dzenita Hasanbasic, Christoph Heesen, Harald Hegen, Thomas Henze, Peter Huppke, Veronika Kana, Michael Khalil, Ruth Kirschner-Hermanns, Thomas Korn, Tania Kümpfel, Sabine Lamprecht, Uwe Meier, Gerd Meyer zu Horste, Mathias Mäurer, Frederike Cosima Oertel, Caroline Pot, Anne-Katrin Pröbstel, Kevin Rostásy, Anke Salmen, Jutta Scheiderbauer, Markus Schmidt, Erwin Stark, Corinna Trebst, Regina Trollmann, Clemens Warnke, Mike P. Wattjes, Benedikt Wiestler, Brigitte Wildemann, Uwe Zimmermann, Klaus Gehring, Achim Berthele, Bernhard Hemmer

• July 14, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum

• by Federico Montini, Ashutosh Mangalam, Burcu Zeydan, Joseph Murray, Orhun H. Kantarci

• July 1, 2026